Ella Automated Immunoassay System
Ella is an automated ELISA platform that fits right on the benchtop of any laboratory. Ella simplifies multiplexing and presents consistent biomarker detection in less than 90 minutes, using only 25 µL of sample, and generating triplicate data, offering more flexibility than other instruments within the immunoassay space.
The supplier does not provide quotations for this product through SelectScience. You can search for similar products in our Product Directory.
Excellent immunoassay platform
Biomarkers
Ella delivers substantial value by reducing assay manual operation by up to 75%, by doing the same reproducible results across multiple users and multiple sites, by getting fully analyzed answers in just 90 minutes or less (even 15 min) and by preserving precious sample volumes.
Review Date: 16 Jan 2025 | Bio-Techne
Reproducible results and time saving
Automated ELISA multiple assay
Easy to use and simple to load the cartridge. Low maintenance due to the absence of fluidic components in the instrument.
Review Date: 21 Feb 2024 | Bio-Techne
Ella is your hands-free immunoassay problem solver. Ella offers cartridges with fully validated assays powered by R&D Systems to deliver fast, reproducible data with no manual steps. Advanced microfluidic circuitry performs every step of the assay process to help eliminate variability and minimize user error. Customizable cartridges can assay up to 8 analytes simultaneously in less than 90 minutes and require only 25µL of sample. Ella assays use fluorescent detection system to deliver excellent low-end sensitivity to detect low expressing proteins and provide a broad dynamic range. Discover the confidence and convenience Ella can bring to your lab.
Eliminate cross-reactivity by detecting each analyte in separate parallel channels.
Less than 7% variability across assay lots.
Get consistent, reproducible answers across multiple users and sites.
Save time and maximize data with preloaded standard curves.
Why does size matter?
In this application note, Bio-Techne introduces Simple Western™, an advanced immunoassay platform that overcomes the limitations of traditional ELISA. Unlike ELISA, Simple Western employs capillary electrophoresis and adds the dimension of molecular weight to protein analysis, providing sensitive, accurate, and reproducible quantitative immunoassay read-outs. While ELISA offers a two-dimensional measurement of antibody binding, Simple Western adds a third dimension by simultaneously measuring antibody binding activity and providing molecular weight size information. This innovative approach enhances the depth and accuracy of protein analysis under varying experimental conditions.
T cell-based therapies: Resources, products, and services for development and manufacturing
T cell-based therapies hold dramatic potential for treating intractable diseases by redirecting the power of living immune cells. The in vivo performance of cell therapies will improve with deeper understanding of cellular behavior, while technological advances contribute to process efficiency, scalability, and safety. In this eBook, explore several of the biological and manufacturing challenges for T cell therapies and discover how Bio-techne's solutions can help overcome these obstacles at each process stage.
Stem cell therapy for macular degeneration: Current insights and future prospects
In recent years, the emergence of cell therapy technologies has piqued great interest from researchers and clinicians seeking to develop targeted age-related macular degeneration (AMD) cell therapies. Through cell therapy, functional retinal pigment epithelium (RPE) cells can be transplanted into a patient’s eye to prevent the loss of photoreceptor cells and thus halt the progressive loss of vision. In this whitepaper from Bio-Techne, explore the current landscape of AMD cell therapy, and examine the future prospects and challenges for this exciting emerging technology.
